← Eichor
Study identifier: NCT07445841 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Protecting the Brain From Post-Stroke Cognitive Impairment and Dementia With Multimodal Exercise Training

Condition: Stroke  ·  Sponsor: McGill University

PhaseNA
Planned participants120
Who can joinAll sexes, 40 Years to 80 Years
Healthy volunteersNo

About this study

The rates of cognitive decline and dementia after stroke are disproportionately high. Strategies that can protect the brain early after the stroke event could reduce the future risk of cognitive decline and dementia in these patients. Although physical exercise is usually recommended after stroke, there is very little information about the protective effect of exercise implemented in early stages of recovery as a potential protective measure against cognitive decline and dementia risk in these patients. This study will investigate the effect of a multimodal exercise intervention implemented early after the stroke event on cognition and on a selected group of markers that can predict cognitive decline and dementia risk.

This description comes directly from the study's public registry record.

Talk to the study team

Marc Roig  ·  514-398-4400  ·  marc.roigpull@mcgill.ca

Always discuss trial participation with your own doctor first.

Locations (2)

McMaster UniversityHamilton, Ontario, CanadaActive Not Recruiting
Jewish Rehabilitation HospitalLaval, Quebec, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07445841